Physician profile
Keith Bloom
NPI 1831177948
$7,761.68
in general payments reported to CMS, 2019-2025
43 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,081 · 2020: $741 · 2021: $1,248 · 2022: $1,508 · 2023: $686 · 2024: $1,364 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,070 · Grant: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,070.10 |
| Grant | $113.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,219.67 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Boston Scientific Corporation | $925.29 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Rezum Generator |
| Janssen Biotech, INC. | $649.57 | 2019-2025 | Erleada, Akeega |
| Abbvie INC. | $505.55 | 2019-2024 | Lupron Depot |
| Sumitomo Pharma America, INC. | $488.43 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $283.27 | 2019-2025 | Posluma |
| Dendreon Pharmaceuticals LLC | $273.95 | 2019-2024 | Provenge |
| Pfizer INC. | $268.47 | 2019-2025 | |
| Olympus America INC. | $221.04 | 2024-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $218.24 | 2019-2025 | Adstiladrin |
| Axonics, INC. | $218.02 | 2022-2024 | Bulkamid, Axonics |
| Antares Pharma, INC. | $215.28 | 2020-2025 | Xyosted |
| Myovant Sciences INC. | $211.77 | 2021-2022 | |
| Neotract INC. | $188.26 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $186.12 | 2022-2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.